- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04032249
Implications of Self-weighing During Weight Loss Treatment
July 22, 2019 updated by: Alberto Hernández de los Reyes, Universidad de Córdoba
Implications of Self-weighing During Weight Loss Treatment: A Pragmatic 6-month Randomized Trial
This study aims to analyze the effectiveness of introducing behavioral elements in a weight loss program, in this case, comparing the difference between self-weighing versus not doing so.
Study Overview
Status
Unknown
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
70
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Córdoba, Spain, 14014
- Universidad de Córdoba
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Having a IMC >25,
- Being sedentary and
- Have not been submitted to a restrictive diet in the 6 months preceding this study
Exclusion Criteria:
- Suffered from type 2 diabetes or renal conditions
- Being pregnancy or attempt at pregnancy,
- Undergoing antidepressant pharmacological treatment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control Group (CG)
Education and modifying diet
|
The control group is subjected to follow a hypocaloric diet and receives information about the benefits of having healthy habits in relation to decision making and food
|
|
Experimental: Intervention Group (IG)
Education, modifying diet and Indications to record self-weighing with a frequency of 2 times per week
|
The control group is subjected to follow a hypocaloric diet and receives information about the benefits of having healthy habits in relation to decision making and food, but also, they will have monitored the self-control of the weight in order to compare the impact of self-weighing versus not doing it
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adherence to dietary pattern will be also measured through personal interview
Time Frame: At baseline (0 years) and followed for 2 years
|
Participants will be subjected for an intervention based on nutritional (control group) and physical education (two intervention arms) during 24 months.
Partial measures will be also taken every week.
In the end of the trial, changes in dietary patterns will be measured comparing means differences between baselines, 3, 6, 12 and 24 months.
|
At baseline (0 years) and followed for 2 years
|
|
Changes from baseline BMI
Time Frame: At baseline (0 years) and followed for 2 years
|
Baseline mean BMI values will be measured and compared at 3, 6, 12 and 24 months.
BMI will be assessed on a monthly basis during nutritional consultation through a Bioelectrical Impedance Analysis method using a Tanita BC-418 Segmental Body Composition Analyser/Scale
|
At baseline (0 years) and followed for 2 years
|
|
Changes from baseline Fatty mass
Time Frame: At baseline (0 years) and followed for 2 years
|
Baseline mean Fatty mass values will be measured and compared at 3, 6, 12 and 24 months.
Fatty mass will be assessed on a monthly basis during nutritional consultation through a Bioelectrical Impedance Analysis method using a Tanita BC-418 Segmental Body Composition Analyser/Scale.
Fatty mass is measured as a percentage.
|
At baseline (0 years) and followed for 2 years
|
|
Changes from baseline Free-fatty mass
Time Frame: At baseline (0 years) and followed for 2 years
|
Baseline mean Free-fatty mass values will be measured and compared at 3, 6, 12 and 24 months.
Free-fatty mass will be assessed on a monthly basis during nutritional consultation through a Bioelectrical Impedance Analysis method using a Tanita BC-418 Segmental Body Composition Analyser/Scale.
Fatty mass is measured as a percentage.
|
At baseline (0 years) and followed for 2 years
|
|
Changes from baseline Muscular Mass
Time Frame: At baseline (0 years) and followed for 2 years
|
Baseline mean Muscular Mass values will be measured and compared at 3, 6, 12 and 24 months.
Muscular Mass will be assessed on a monthly basis during nutritional consultation through a Bioelectrical Impedance Analysis method using a Tanita BC-418 Segmental Body Composition Analyser/Scale.
Fatty mass is measured as a Kg.
|
At baseline (0 years) and followed for 2 years
|
|
Changes from baseline Corporal Water
Time Frame: At baseline (0 years) and followed for 2 years
|
Baseline mean Corporal Water values will be measured and compared at 3, 6, 12 and 24 months.
Corporal Water will be assessed on a monthly basis during nutritional consultation through a Bioelectrical Impedance Analysis method using a Tanita BC-418 Segmental Body Composition Analyser/Scale.
Fatty mass is measured as a Kg.
|
At baseline (0 years) and followed for 2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2018
Primary Completion (Actual)
December 15, 2018
Study Completion (Anticipated)
June 1, 2020
Study Registration Dates
First Submitted
July 22, 2019
First Submitted That Met QC Criteria
July 22, 2019
First Posted (Actual)
July 25, 2019
Study Record Updates
Last Update Posted (Actual)
July 25, 2019
Last Update Submitted That Met QC Criteria
July 22, 2019
Last Verified
July 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- P5_A284R4156
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight and Obesity
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Institut Investigacio Sanitaria Pere VirgiliCompletedObesity, Childhood | Overweight and Obesity | Overweight, ChildhoodSpain
-
National University Health System, SingaporeActive, not recruitingObesity | Overweight and/or Obesity | Overweight or Obese Adults | Overweight , ObesitySingapore
-
National Taiwan University HospitalCompleted
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
PfizerRecruitingObesity | Overnutrition | Nutrition Disorders | Overweight | Body Weight | Overweight or Obesity | Overweight and/or Obesity | Nutritional and Metabolic DiseasesUnited States
-
University of Texas Southwestern Medical CenterChildren's Medical Center DallasRecruitingPediatric Obesity | Pediatric Overweight | Overweight , ObesityUnited States
-
Universidade do Extremo Sul Catarinense - Unidade...RecruitingObesity | Overweight and Obesity | Obesity; Endocrine | Overweight, Obesity and Other HyperalimentationBrazil
-
Mexican National Institute of Public HealthUNICEFCompleted
-
Universidade do PortoFundação para a Ciência e a Tecnologia; Administração Regional de Saúde do... and other collaboratorsCompletedOverweight and ObesityPortugal
Clinical Trials on Control Group (CG)
-
Universiti Putra MalaysiaNot yet recruitingCardiometabolic SyndromeMalaysia
-
Universidad de CórdobaUnknown
-
Fundación Pública Andaluza para la Investigación...University of MalagaUnknownDepression | Type 1 Diabetes MellitusSpain
-
Istanbul Arel UniversityCompletedShoulder Impingement Syndrome | Trigger Point PainTurkey
-
Novindiet ClinicTehran University of Medical Sciences; University of NottinghamCompletedObesity | OverweightIran, Islamic Republic of
-
Mieko Cláudia MiuraHospital do CoracaoCompleted
-
University of VirginiaRivanna Medical, LLCCompleted
-
Washington University School of MedicineSpinal Cord Injury/Disease Research ProgramCompleted
-
University of Sao PauloCompleted
-
University of SevilleCompleted